Laboratoire de Production Iso 7
© A. Moisan EFS-RA

ECELLFRANCE offers to assist academics and industrials with the implementation of their preclinical and/or clinical programs in the field of cell-based therapies.

 The infrastructure provides services covering the entire MSC-based production and development pipeline:




+ Mesenchymal Stem Cell (MSC) production

   Clinical batches meeting the European directive 1394/2007 on ATMP


+ Quality control, potency tests and MSC safety testing


+ Immunomonitoring of MSC treated patients

   Phenotypic analysis of sub-populations of immune cells


+ Preclinical studies

  • MSC efficiency in validated disease models

-    Osteoarticular diseases
-    Auto-immune diseases
-    Cutanuous conditions
-    Ischemia
-    Stroke and neurological disorders

  • Regulatory pre-clinical studies

-    Biodistribution
-    Pharmacotoxicology


+ Assistance with regulatory dossier
   Investigator brochure, IMPD, CRF


+ Assistance with Phase I and II clinical trials
   Design, methodology, statistics, meeting with the French health authorities (CPP).


For service requests, you may apply by filling the online submission form


For more information contact us